BAX and breast carcinoma: We demonstrated that deletion or pharmacological inhibition of MCL-1 with either S63845 or A1210477 BH3-mimetics impaired the tumorsphere-forming capacity of breast cancer cells, and that genetic ablation of pro-apoptotic effector proteins BAX and BAK abrogates this effect [118].